| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corrections |
, a Chemosensitivity Determinant
, a chemosensitivity determinant, in the October 1, 2005 issue of Cancer Research (1), the last sentence of the second to last paragraph in the Discussion section should have read as follows: Thus, it is clear from these results that perhaps transcriptional activation of IGFBP3 and repression of BCL2A1 may contribute to AP-2
induced apoptosis. References
status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Cancer Res 2005;65:862834.
| ||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |